These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 690027)

  • 1. Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients.
    Fillastre JP; Leroy A; Godin M; Oksenhendler G; Humbert G
    J Antimicrob Chemother; 1978 Jul; 4(B):79-83. PubMed ID: 690027
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A; Canonne MA; Fillastre JP; Humbert G
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitin.
    Sonneville PF; Albert KS; Skeggs H; Gentner H; Kwan KC; Martin CM
    Eur J Clin Pharmacol; 1977 Dec; 12(4):273-9. PubMed ID: 590313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical pharmacology of intravenous cefoxitin and cephalothin.
    Sonneville PF; Kartodirdjo RR; Skeggs H; Till AE; Martin CM
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):397-403. PubMed ID: 971703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.
    Andriole VT
    J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and pharmacokinetics of cefoxitin sodium.
    Schrogie JJ; Davies RO; Yeh KC; Rogers D; Holmes GI; Skeggs H; Martin CM
    J Antimicrob Chemother; 1978 Jul; 4(B):69-78. PubMed ID: 99418
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.
    Kirby WM; De Maine JB; Serrill WS
    Postgrad Med J; 1971 Feb; 47():Suppl:41-6. PubMed ID: 5556189
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of cefoxitin in patients with pleural effusion on a multiple dosage regimen.
    Garcia MJ; Otero MJ; Barrueco M; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):300-3. PubMed ID: 6746153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy.
    Giamarellou H; Gazis J; Petrikkos G; Antsaklis A; Aravantinos D; Daikos GK
    Am J Obstet Gynecol; 1983 Dec; 147(8):914-9. PubMed ID: 6359888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of cefuroxime and cefoxitin in experimentally induced pleurisy in the rat].
    Benoni G; Franco L; Conforti A; Totorizzo A; Velo GP
    G Ital Chemioter; 1981; 28(1-2):33-9. PubMed ID: 7347703
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of the serum half-life of a new cephalosporin in uraemic patients.
    Fillastre JP; Humbert G; Acar J; Malandain H; Robert M; Dubois D; Daufresne MF
    Proc Eur Dial Transplant Assoc; 1972; 9():577-80. PubMed ID: 4668933
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of cefazolin in normal and uremic subjects.
    Welling PG; Craig WA; Gordon AL; Kunin CM
    Clin Pharmacol Ther; 1974 Apr; 15(4):344-53. PubMed ID: 4821438
    [No Abstract]   [Full Text] [Related]  

  • 13. Cefamandole kinetics in uremic patients undergoing hemodialysis.
    Gambertoglio JG; Aziz NS; Lin ET; Grausz H; Naughton JL; Benet LZ
    Clin Pharmacol Ther; 1979 Nov; 26(5):592-9. PubMed ID: 498702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Penetration activities of cefoxitin into different human tissues. An experimental study (author's transl)].
    Plaue R; Müller O; Jenne V; Fabricius K; Bethke RO
    Med Klin; 1979 Mar; 74(13):481-7. PubMed ID: 431475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and hemodialyzability of cefazolin in uremic patients.
    Craig CP; Rifkin SI
    Clin Pharmacol Ther; 1976 Jun; 19(6):825-9. PubMed ID: 773590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion.
    Otero MJ; Garcia MJ; Barrueco M; Dominguez-Gil A; Gomez F; Portugal Alvarez J
    Eur J Clin Pharmacol; 1984; 26(3):389-92. PubMed ID: 6734700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cefoperazone and cefoxitin concentrations in serum and pelvic tissue of abdominal hysterectomy patients.
    Bawdon RE; Hemsell DL; Guss SP
    Antimicrob Agents Chemother; 1982 Dec; 22(6):999-1003. PubMed ID: 6218781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of intravenous and intraperitoneal cefoxitin during chronic intermittent peritoneal dialysis.
    Vlasses PH; D'Silva H; Rocci ML; Koplin JR; Bland JA; Siciliano EG; Ferguson RK
    Am J Kidney Dis; 1983 Jul; 3(1):67-70. PubMed ID: 6869373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefoxitin, a semi-synthetic cephamycin antibiotic. Metabolism in rats with renal insufficiency.
    Sasano H; Fujimoto T; Une T; Tachizawa H; Ogawa H
    Arzneimittelforschung; 1978; 28(9):1596-9. PubMed ID: 582562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural fluid levels of cefoxitin in patients with renal impairment.
    Barrueco M; Otero MJ; Garcia MJ; Lanao JM; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):485-9. PubMed ID: 3781682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.